BridgeMD
New treatment option for Cataract
Official title Postoperative Rotational Dynamics of Three Toric Intraocular Lens Designs
ClinicalTrials.gov ID: NCT07453992
What this study is testing
- What it's testing
- This prospective comparative cohort study evaluates and compares postoperative rotational stability and time-course dynamics of three commercially available toric intraocular lenses (TECNIS Toric II [ZCU], AcrySof IQ Toric, and AT TORBI 709M) after phacoemulsification cataract surgery. Rotation is quantified by registering postoperative retroillumination photographs to the end-of-surgery baseline using iris/scleral landmarks, with follow-up at postoperative day 1, day 3, week 1, week 2, month 1, and month 3.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults aged 18 years or older with age-related cataract scheduled for phacoemulsification cataract surgery.
- Presence of regular corneal astigmatism requiring toric intraocular lens implantation.
- Eligible for implantation of one of the three study toric intraocular lenses based on preoperative evaluation.
- Ability to understand the study procedures and provide written informed consent.
You likely can't join if
- History of prior ocular surgery in the study eye.
- History of ocular trauma in the study eye.
- Irregular corneal astigmatism or corneal pathology affecting reliable biometric measurement.
- Intraoperative complications, including anterior capsular tear or posterior capsular rupture.
- Inadequate pupillary dilation during surgery or postoperative examinations.
- Evidence of zonular weakness, zonular dialysis, or lens subluxation.
See the full eligibility criteria
- Adults aged 18 years or older with age-related cataract scheduled for phacoemulsification cataract surgery.
- Presence of regular corneal astigmatism requiring toric intraocular lens implantation.
- Eligible for implantation of one of the three study toric intraocular lenses based on preoperative evaluation.
- Ability to understand the study procedures and provide written informed consent.
- History of prior ocular surgery in the study eye.
- History of ocular trauma in the study eye.
- Irregular corneal astigmatism or corneal pathology affecting reliable biometric measurement.
- Intraoperative complications, including anterior capsular tear or posterior capsular rupture.
- Inadequate pupillary dilation during surgery or postoperative examinations.
- Evidence of zonular weakness, zonular dialysis, or lens subluxation.
- Active ocular infection or inflammation.
- Any other ocular or systemic condition judged by the investigator to potentially affect intraocular lens stability or study outcomes.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.